Sunitinib therapy for imatinib-resistant and/or intolerant gastrointestinal stromal tumors: comparison of safety and efficacy between standard and reduced dosage regimens.
- Resource Type
- Article
- Source
- Japanese Journal of Clinical Oncology; Apr2023, Vol. 53 Issue 4, p297-303, 7p
- Subject
- Language
- ISSN
- 03682811